Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Axonics, Inc. | axnx-20201231.htm |
| EX-32.2 - EX-32.2 - Axonics, Inc. | a12312020-exhibit322.htm |
| EX-32.1 - EX-32.1 - Axonics, Inc. | a12312020-exhibit321.htm |
| EX-31.2 - EX-31.2 - Axonics, Inc. | a12312020-exhibit312.htm |
| EX-31.1 - EX-31.1 - Axonics, Inc. | a12312020-exhibit311.htm |
| EX-21.1 - EX-21.1 - Axonics, Inc. | a12312020-exhibit211.htm |
| EX-4.4 - EX-4.4 - Axonics, Inc. | a12312020-exhibit44.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Axonics Modulation Technologies, Inc.
Irvine, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-234546) and Form S-8 (No.333-228170) of Axonics Modulation Technologies, Inc. of our reports dated March 1, 2021, relating to the consolidated financial statements and the effectiveness of Axonics Modulation Technologies, Inc.’s internal control over financial reporting, which appears in this Form 10-K.
/s/ BDO USA, LLP
Costa Mesa, California
March 1, 2021